The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement

被引：29

作者：

Cooperberg, Matthew R. ^{[1
,2
]}

Carroll, Peter R. ^{[1
]}

Dall'Era, Marc A. ^{[3
]}

Davies, Benjamin J. ^{[4
]}

Davis, John W. ^{[5
]}

Eggener, Scott E. ^{[6
]}

Feng, Felix Y. ^{[1
,7
]}

Lin, Daniel W. ^{[8
,9
]}

Morgan, Todd M. ^{[10
]}

Morgans, Alicia K. ^{[11
]}

Spratt, Daniel E. ^{[12
]}

Taneja, Samir S. ^{[13
]}

Penson, David F. ^{[14
,15
]}

机构：

[1] UCSF Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA USA

[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA

[3] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA

[4] Univ Pittsburgh, Med Ctr, Dept Urol, Pittsburgh, PA USA

[5] MD Anderson Canc Ctr, Houston, TX USA

[6] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA

[7] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA

[8] Univ Washington, Dept Urol, Seattle, WA 98195 USA

[9] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA

[10] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA

[11] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA

[12] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI USA

[13] NYU Langone Hlth, New York, NY USA

[14] Vanderbilt Univ, Sch Med, Dept Urol, Nashville, TN 37212 USA

[15] Tennessee Valley Hlth Care Syst, Nashville, TN USA

来源：

EUROPEAN UROLOGY | 2019年 / 76卷 / 03期

关键词：

RISK STRATIFICATION; VALIDATION; NUMERACY;

D O I：

10.1016/j.eururo.2019.05.013

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：268 / 272

页数：5

共 50 条

[21] San Francisco State University Archives
Eliassen, Meredith
[J]. CALIFORNIA HISTORY, 2019, 96 (01) : 33 - 45
[22] San Francisco scores in state consolidation
[J]. ENR (Engineering News-Record), 1994, 233 (17):
[23] NEXA - SCIENCE-HUMANITIES CONVERGENCE PROGRAM AT SAN-FRANCISCO-STATE-UNIVERSITY
GREGORY, MS
[J]. LIBERAL EDUCATION, 1979, 65 (01): : 66 - 91
[24] Epigenetic biomarkers for detection of cancer: State of the science
Cairns, Paul
[J]. CANCER BIOMARKERS, 2008, 4 (03) : 128 - 128
[25] Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement
Klotz, Laurence
Shayegan, Bobby
Guillemette, Chantal
Collins, Loretta L.
Gotto, Geoffrey
Guerette, Dominique
Jammal, Marie-Paule
Pickles, Tom
Richard, Patrick O.
Saad, Fred
[J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2018, 12 (02): : 30 - 37
[26] Prognostic factors in prostate cancer - College of American Pathologists Consensus Statement 1999
Bostwick, DG
Grignon, DJ
Hammond, MEH
Amin, MB
Cohen, M
Crawford, D
Gospadarowicz, M
Kaplan, RS
Miller, DS
Montironi, R
Pajak, TF
Pollack, A
Srigley, JR
Yarbro, JW
[J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2000, 124 (07) : 995 - 1000
[27] External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score
Zhao, Kevin H.
Hernandez, David J.
Han, Misop
Humphreys, Elizabeth B.
Mangold, Leslie A.
Partin, Alan W.
[J]. UROLOGY, 2008, 72 (02) : 396 - 400
[28] Censoring breast cancer in San Francisco
Helwig, D
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 162 (09) : 1338 - 1338
[29] Healing the 'money cancer' - San Francisco
Hill, S
[J]. NATION, 2003, 276 (08) : 2 - +
[30] Consensus statement on lung cancer
Biesalski, HK
deMesquita, BB
Chesson, A
Chytil, F
Grinble, R
Hermus, RIJ
Kohrle, J
Lotan, R
Norpoth, K
Pastorino, U
Thurnham, D
[J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 1997, 6 (04) : 316 - 322

← 1 2 3 4 5 →